Jason Cassorla
Stock Analyst at Citigroup
(2.41)
# 2,464
Out of 4,761 analysts
40
Total ratings
50%
Success rate
0.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Cassorla
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Reinstates: Buy | $45 | $12.79 | +251.84% | 3 | Sep 11, 2024 | |
| SGRY Surgery Partners | Maintains: Buy | $38 → $36 | $25.31 | +42.24% | 6 | Aug 7, 2024 | |
| THC Tenet Healthcare | Maintains: Buy | $139 → $171 | $129.60 | +31.94% | 7 | Jul 25, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $170 → $193 | $180.03 | +7.20% | 5 | Feb 29, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $324 → $279 | $316.42 | -11.83% | 5 | Oct 25, 2023 | |
| CLOV Clover Health Investments | Maintains: Neutral | $1 → $1.5 | $4.40 | -65.91% | 3 | Aug 11, 2023 | |
| CYH Community Health Systems | Maintains: Buy | $9 → $7 | $3.51 | +99.43% | 8 | May 3, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $16 → $18 | $8.14 | +121.13% | 2 | Feb 17, 2023 | |
| INNV InnovAge Holding | Maintains: Neutral | $5 → $8 | $3.32 | +140.96% | 1 | Nov 16, 2022 |
PACS Group
Sep 11, 2024
Reinstates: Buy
Price Target: $45
Current: $12.79
Upside: +251.84%
Surgery Partners
Aug 7, 2024
Maintains: Buy
Price Target: $38 → $36
Current: $25.31
Upside: +42.24%
Tenet Healthcare
Jul 25, 2024
Maintains: Buy
Price Target: $139 → $171
Current: $129.60
Upside: +31.94%
Universal Health Services
Feb 29, 2024
Maintains: Buy
Price Target: $170 → $193
Current: $180.03
Upside: +7.20%
HCA Healthcare
Oct 25, 2023
Maintains: Buy
Price Target: $324 → $279
Current: $316.42
Upside: -11.83%
Clover Health Investments
Aug 11, 2023
Maintains: Neutral
Price Target: $1 → $1.5
Current: $4.40
Upside: -65.91%
Community Health Systems
May 3, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $3.51
Upside: +99.43%
Enhabit
Feb 17, 2023
Maintains: Neutral
Price Target: $16 → $18
Current: $8.14
Upside: +121.13%
InnovAge Holding
Nov 16, 2022
Maintains: Neutral
Price Target: $5 → $8
Current: $3.32
Upside: +140.96%